JPRN-UMIN000024302Recruiting未知
Analysis of circulating tumor cells(CTCs) and clinical significance of CTCs; human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trial - Analysis of circulating tumor cells in the clinical study of ANP administration for lung cancer surgery (JANP study) (Subanalysis of JANP study)
Osaka University Graduate School of Medicine0 sites500 target enrollmentStarted: October 19, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Thin-section CT fulfills the proportion of maximum diameter of the tumor itself to consolidation is less than 0.25. 2. Patient with active the other concurrent malignant diseases. 3. Women during pregnancy or breast-feeding. 4. Psychosis. 5. Systemic steroids or immunosuppressive agents medication. 6. Uncontrollable infectious disease, autoimmune disease, or the other severe comorbidities. 7. History of right ventricular infarction. 8. Severe hypotension 9. Other conditions judged ineligible by physician
Investigators
Similar Trials
Recruiting
Not Applicable
Determining Circulating Tumour Cells (CTC) and other rare cells in cancer patients and for early detection screeningCancerACTRN12614001143617Dr Karin Ried2,000
Recruiting
Not Applicable
CTCs in Lung MalignanciesCTRI/2021/08/035450Datar Cancer Genetics Private Limited
Active, not recruiting
Not Applicable
Evaluation of Circulating Tumors Cells (CTCs) as Potential Surrogate Marker for Further Definition und Subclassification of non metastatic High-Risk Castration Resistant Prostate Cancer PatientsC61Malignant neoplasm of prostateprostate cancerDRKS00008554OnkoDataMed GmbH5
Completed
Not Applicable
Observational study in hepatocellular carcinoma (Liver Disease)CTRI/2018/02/011987Institute of liver and Biliary Sciences53
Completed
Not Applicable
Detection of circulating tumor cells (CTC) with novel viral marker (OBP-401) for patients with prostate cancerProstate cancerJPRN-UMIN000010410Department of Urology, Kobe university graduate school of medicine50